Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.30 |
| ▸ | PRKCG | P05129 | 1/20 | 0.30 |
| ▸ | PRKCB | P05771 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
| ▸ | PRKCH | P24723 | 1/20 | 0.30 |
| ▸ | PRKCI | P41743 | 1/20 | 0.30 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.30 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.30 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.30 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.30 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4448859 | 0.93 | LMNA (0.40) | TSHRLMNAACE2MAPTPRKD3 | |
| SCHEMBL21293885 | 0.91 | ACE2 (0.39) | TSHRLMNAACE2PRKD3PRKCG | |
| SCHEMBL4449766 | 0.90 | ACE2 (0.38) | TSHRLMNAACE2MAPTPRKD3 | |
| SCHEMBL102559 | 0.90 | — | — | |
| SCHEMBL10528855 | 0.88 | ACE2 (0.45) | LMNAACE2MAPTPRKD3PRKCG | |
| SCHEMBL1463600 | 0.86 | ACE2 (0.48) | TSHRLMNAACE2PRKD3PRKCG | |
| SCHEMBL28154757 | 0.86 | ACE2 (0.48) | TSHRLMNAACE2PRKD3PRKCG | |
| SCHEMBL28845556 | 0.86 | ACE2 (0.48) | TSHRLMNAACE2PRKD3PRKCG | |
| SCHEMBL28153758 | 0.86 | ACE2 (0.48) | TSHRLMNAACE2PRKD3PRKCG | |
| SCHEMBL28270184 | 0.86 | ACE2 (0.48) | TSHRLMNAACE2PRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255059-B2 | Method for producing an alkyl 3-hydroxybutyrate | EASTMAN CHEMICAL COMPANY (US) | 2016-02-09 | — | — | US | claimed |
| US-9249378-B2 | Aqueous cleaning compositions having enhanced properties | EASTMAN CHEMICAL COMPANY (US) | 2016-02-02 | — | — | US | claimed |
| US-20150038734-A1 | METHOD FOR PRODUCING AN ALKYL 3-HYDROXYBUTYRATE | EASTMAN CHEMICAL COMPANY (US) | 2015-02-05 | — | — | US | claimed |
| CN-115052875-B | 4- (4, 5-Dihydroisoxazol-3-yl) thiazol-2-yl) piperidine-thioimine or sulphoxide-imine derivatives and related compounds as fungicides for crop protection | PI工业有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-112004813-B | Oxadiazole compounds for controlling phytopathogenic fungi | PI工业有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-111670186-B | Pyrazolopyridine-diamides, their use as pesticides and process for their preparation | PI工业有限公司 | 2023-10-17 | — | — | CN | disclosed |
| CN-112469687-B | New method for preparing o-carboxamido benzamide compound | PI工业有限公司 | 2023-10-13 | — | — | CN | disclosed |
| US-20230317953-A1 | COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, LITHIUM ION BATTERY, AND METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES | APB CORPORATION (JP) | 2023-10-05 | — | — | US | disclosed |
| EP-4203099-A1 | COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, LITHIUM ION BATTERY, AND METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES | APB Corporation (JP) | 2023-06-28 | — | — | EP | disclosed |
| CN-110574195-B | Binder for lithium ion electrode, electrode for lithium ion battery, and method for producing electrode for lithium ion battery | 三洋化成工业株式会社 | 2023-03-31 | — | — | CN | disclosed |
| US-20230033163-A1 | COATED POSITIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR A LITHIUM-ION BATTERY, POSITIVE ELECTRODE FOR A LITHIUM-ION BATTERY, AND PRODUCTION METHOD OF COATED POSITIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR A LITHIUM-ION BATTERY | APB CORPORATION (JP) | 2023-02-02 | — | — | US | disclosed |
| EP-0889057-B1 | Process for hydrogenating conjugated diene polymer | ASAHI CHEMICAL IND (JP) | 2003-01-08 | — | — | EP | disclosed |
| CN-1364161-A | N-substituted perhydrodiazines | BASF AG (DE) | 2002-08-14 | — | — | CN | disclosed |
| CN-1362950-A | Substituted ureas | BASF AG (DE) | 2002-08-07 | — | — | CN | disclosed |
| EP-1187819-A1 | N-SUBSTITUTED PERHYDRO DIAZINE | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-20 | — | — | EP | disclosed |
| EP-1187820-A1 | SUBSTITUTED UREAS | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-20 | — | — | EP | disclosed |
| WO-2001000602-A1 | SUBSTITUTED UREAS | BASF AKTIENGESELLSCHAFT (DE) | 2001-01-04 | — | — | WO | disclosed |
| WO-2001000600-A1 | N-SUBSTITUTED PERHYDRO DIAZINE | BASF AKTIENGESELLSCHAFT (DE) | 2001-01-04 | — | — | WO | disclosed |
| US-5886108-A | Process for hydrogenating conjugated diene polymer | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1999-03-23 | — | — | US | disclosed |
| EP-0889057-A1 | Process for hydrogenating conjugated diene polymer | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1999-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038734-A1 | METHOD FOR PRODUCING AN ALKYL 3-HYDROXYBUTYRATE | HSD17B10, ABAT, HSD17B12 | TSHR 2999/4885LMNA 3157/4885ACE2 3020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.